Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...

In patients with dry eye disease, Miebo before cataract surgery had no impact on the accuracy of preoperative measurements ...

IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will ...

IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global ...

The offering is expected to close on February 18, 2026, subject to the satisfaction of customary closing conditions. Sidley Austin LLP served as counsel to Opus Genetics in connection with the ...

USA: A small-volume ophthalmic spray delivering mydriatic medications may offer a child-friendly alternative to traditional eye drops for pupillary dilation, a randomized clinical trial published in ...

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global biopharmaceutical ...

Glaukos Corporation activity on NYSE Composite highlights revenue growth, product expansion, and market response within the ophthalmic medical technology sector.

For decades, the city of Kota in Rajasthan has been synonymous with academic coaching, serving as the intense crucible for India's future engineers and doctors. However, a quiet but powerful ...

Independent Clinical Trial Site Grows Through Excellence In Trial Compliance LOUISVILLE, KY, UNITED STATES, January 30, ...

Rahul Tonk, MD, MBA attended Envision Summit 2026 to present on refractive surgery, dry eye, and ocular surface disease. In the CE Spotlight Symposium titled “Emerging Therapeutic Advancements in Dry ...

Two years ago, I moved to New Hampshire to begin my optometry career. I was drawn to practice in the Granite State because I ...